2m 2m 2m 2m 2m 2m 2m
ABSCI (ABSI)
NASDAQ
$5.86-$0.49 (-7.70%)
Price as of Jun 03, 2026 6:20 PM EDT- $1.1BMarket Cap
- 128.42%1-Year Change
- BiotechnologyIndustry
ABSCI (ABSI)
$5.86-$0.49 (-7.70%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.8M -38.24% | 4.5M -20.71% | 5.7M -0.50% | 5.7M +20.18% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.8M -38.24% | 4.5M -20.71% | 5.7M -0.50% | 5.7M +20.18% | |
Sales and Marketing Expense | 35.1M -3.09% | 36.2M -4.38% | 37.8M -6.71% | 40.6M +40.90% | |
Research and Development Expense | -81.4M +27.50% | -63.9M +32.85% | -48.1M -18.40% | -58.9M +32.12% | |
Depreciation and Amortization Expense | 11.7M -12.30% | 13.4M -4.36% | 14.0M +7.38% | 13.0M +95.93% | |
Total Operating Expenses | 123.1M +8.55% | 113.4M -6.44% | 121.2M +7.77% | 112.5M +40.59% | |
Operating Profit | -120.3M +10.50% | -108.9M -5.74% | -115.5M +8.21% | -106.8M +41.88% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.0M +3.91% | -972,000 -71.68% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -1.0M +3.91% | -972,000 -71.68% | |
Total Nonoperating Income and Expense | 5.2M -11.09% | 5.9M +15.90% | 5.0M +264.55% | 1.4M +104.00% | |
Income before Taxes | -115.1M +11.72% | -103.0M -6.73% | -110.5M +4.84% | -105.4M -4.09% | |
Income Taxes | 69,000 -1.43% | 70,000 -30.00% | 100,000 +121.69% | -461,000 -94.82% | |
Extraordinary Items | N/A N/A | 1.4M N/A | N/A N/A | N/A N/A | |
Net Income | -115.2M +11.71% | -103.1M -6.75% | -110.6M +5.40% | -104.9M +3.91% | |
Net Income from Continuing Operations Applicable to Common | -115.1M +11.72% | -103.0M -6.73% | -110.5M +5.30% | -104.9M +1.61% | |
Basic EPS and Net Income | -0.84 -10.64% | -0.94 -21.67% | -1.20 +4.35% | -1.15 -44.71% | |
Diluted EPS and Net Income | -0.84 -10.64% | -0.94 -21.67% | -1.20 +4.35% | -1.15 -44.71% | |
Basic Weighted Average Shares | 136.8M +24.07% | 110.2M +19.79% | 92.0M +1.30% | 90.8M +82.84% | |
Diluted Weighted Average Shares | 136.8M +24.07% | 110.2M +19.79% | 92.0M +1.30% | 90.8M +82.84% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 20.0M -51.41% | 41.2M -43.05% | 72.4M +20.69% | 60.0M -76.26% | |
Short-Term Investments | 124.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 144.3M +250.11% | 41.2M -43.05% | 72.4M +20.69% | 60.0M -76.26% | |
Total Current Assets | 149.6M +11.76% | 133.8M +10.99% | 120.6M -35.47% | 186.9M -31.57% | |
Accumulated Depreciation | 35.5M +12.51% | 31.6M +31.59% | 24.0M +57.80% | 15.2M +138.25% | |
Property and Plant and Equipment and Net | 20.9M -28.48% | 29.2M -29.43% | 41.3M -21.61% | 52.7M +1.17% | |
Total Long-Term Assets | 383,000 -45.67% | 705,000 -54.13% | 1.5M +19.89% | 1.3M -0.85% | |
Total Assets | 216.3M +1.26% | 213.6M -1.70% | 217.3M -32.31% | 321.0M -24.68% | |
Income Taxes Payable | N/A N/A | N/A N/A | 186,000 -21.85% | 238,000 -67.97% | |
Total Short-Term Debt | 873,000 -68.06% | 2.7M -16.11% | 3.3M +10.59% | 2.9M +22.75% | |
Total Current Liabilities | 22.8M -20.56% | 28.7M -3.05% | 29.6M -2.35% | 30.3M -10.60% | |
Total Long-Term Debt | 0 -100.00% | 1.3M -73.03% | 4.7M -41.63% | 8.0M +610.32% | |
Total Long-Term Liabilities | 1.0M +669.17% | 133,000 +303.03% | 33,000 -5.71% | 35,000 -99.71% | |
Total Liabilities | 26.8M -22.12% | 34.5M -16.16% | 41.1M -11.74% | 46.6M -22.46% | |
Retained Earnings | -624.8M +22.60% | -509.6M +25.36% | -406.5M +37.36% | -295.9M +54.92% | |
Total Stockholders Equity | 189.4M +5.76% | 179.1M +1.68% | 176.2M -35.80% | 274.4M -25.05% | |
Total Shares Outstanding | 151.5M +31.34% | 115.4M +23.93% | 93.1M +0.73% | 92.4M -0.26% | |
Cash Flow | |||||
Cash from Operating Activities | -92.9M +28.35% | -72.4M +12.01% | -64.6M -20.54% | -81.3M +34.23% | |
Capital Expenditures | 1.1M +174.01% | 404,000 -53.02% | 860,000 -94.68% | 16.2M -57.49% | |
Cash from Investing Activities | -50.2M +20.64% | -41.6M -150.74% | 81.9M +164.53% | -127.0M +88.46% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 105.9M +28.38% | 82.5M +1,940.87% | -4.5M -185.60% | 5.2M -98.44% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -4,297.04% +78.92% | -2,401.59% +18.88% | -2,020.20% +8.76% | -1,857.49% N/A | |
Return on Assets | -53.59% +11.97% | -47.86% +16.50% | -41.08% +46.30% | -28.08% N/A | |
Return on Equity | -62.50% +7.69% | -58.04% +18.26% | -49.08% +49.82% | -32.76% N/A | |
Revenue Growth | -38.24% +84.70% | -20.71% +4,003.55% | -0.50% -102.50% | 20.18% N/A | |
Current Ratio | 6.57 +40.68% | 4.67 +14.48% | 4.08 -33.92% | 6.17 N/A | |
Cash Ratio | 0.88 -38.84% | 1.44 -41.25% | 2.45 +23.60% | 1.98 N/A | |
Debt-to-Equity Ratio | 0.005 -79.37% | 0.02 -50.33% | 0.04 +12.81% | 0.04 N/A | |
Debt-to-Assets Ratio | 0.004 -78.61% | 0.02 -48.63% | 0.04 +7.06% | 0.03 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow